Macquarie Group »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Macquarie Group

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Macquarie Group from 13F filings

Historical chart of Macquarie Group investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Macquarie Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Macquarie Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.9M 1.7M 1.11
2024-03-31 $2.6M 2.7M 0.98
2023-12-31 $2.5M 2.7M 0.93
2023-09-30 $2.5M 2.7M 0.94

More positions owned by Macquarie Group

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
UnitedHealth (UNH)
Motorola Solutions Com New (MSI)
CoStar (CSGP)
Pinterest Cl A (PINS)
Merck & Co (MRK)
Exxon Mobil Corporation (XOM)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Cognizant Technology Solutio Cl A (CTSH)

View all positions for Macquarie Group

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Citadel Advisors
MacKay Shields
Lazard Asset Management
Calamos Advisors
Polar Securities
BlackRock
Wolverine Asset Management
Ing Investment Management
Wells Fargo & Company
CNH Partners
State Street Corporation
BlackRock
Absolute Investment Advisers
Glazer Capital

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1